Leucogenics Company
The purpose of the Leucogenics is the research, development and marketing of immunosuppressive therapies and diagnoses. Leucogenics may acquire, manage and sell real estate as well as any business directly or indirectly related to the purpose of the Company. The company also participates in other, domestic or foreign companies of all kinds.
Headquarters:
Basel, Basel-Stadt, Switzerland
Funding Status:
Undisclosed
Employee Number:
Undisclosed
Investment Stage:
N/A
Number Of Exists:
N/A
Technology:
Precision Medicine
Investor Type:
N/A
Founded Date:
2009
Industry:
P3 Medicine